Agios Pharmaceuticals AGIO Convertible Preferred Stock Authorized Shares
Convertible Preferred Stock Authorized Shares at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's convertible preferred stock authorized shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's convertible preferred stock authorized shares?
- Agios Pharmaceuticals (AGIO) reported convertible preferred stock authorized shares of 25M in Q1 2026.
- How has Agios Pharmaceuticals's convertible preferred stock authorized shares changed year-over-year?
- Agios Pharmaceuticals's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 25M to 25M.
- What is the long-term trend for Agios Pharmaceuticals's convertible preferred stock authorized shares?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 25M to 25M.
- What does convertible preferred stock authorized shares mean?
- Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.